63. Summers BJ, Cougle JR: Modifying interpretation biases in body dysmorphic disorder: Evaluation of a brief computerized treatment. Behav Res Ther. 2016;87:117–27. 10.1016/j.brat.2016.09.005 [PubMed] [Cross Ref] F1000 Recommendation
64. Phillips KA: Body dysmorphic disorder: recognizing and treating imagined ugliness. World Psychiatry. 2004;3(1):12–7. [PMC free article] [PubMed]
65. Chosak A, Marques L, Greenberg JL, et al. : Body dysmorphic disorder and obsessive-compulsive disorder: similarities, differences and the classification debate. Expert Rev Neurother. 2008;8(8):1209–18. 10.1586/14737175.8.8.1209 [PubMed] [Cross Ref]
66. Fang A, Matheny NL, Wilhelm S: Body dysmorphic disorder. Psychiatr Clin North Am. 2014;37(3):287–300. 10.1016/j.psc.2014.05.003 [PubMed] [Cross Ref]
67. Vasudeva SB, Hollander E: Body Dysmorphic Disorder in Patients With Autism Spectrum Disorder: A Reflection of Increased Local Processing and Self-Focus. Am J Psychiatry. 2017;174(4):313–6. 10.1176/appi.ajp.2016.16050559 [PubMed] [Cross Ref]
68. Ferguson JM: SSRI Antidepressant Medications: Adverse Effects and Tolerability. Prim Care Companion J Clin Psychiatry. 2001;3(1):22–7. 10.4088/PCC.v03n0105 [PMC free article] [PubMed] [Cross Ref]
69. Hollander E, Soorya L, Chaplin W, et al. : A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. Am J Psychiatry. 2012;169(3):292–9. 10.1176/appi.ajp.2011.10050764 [PubMed] [Cross Ref]
70. Uzunova G, Pallanti S, Hollander E: Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics. World J Biol Psychiatry. 2016;17(3):174–86. 10.3109/15622975.2015.1085597 [PubMed] [Cross Ref]
71. Enticott PG, Kennedy HA, Zangen A, et al. : Deep repetitive transcranial magnetic stimulation associated with improved social functioning in a young woman with an autism spectrum disorder. J ECT. 2011;27(1):41–3. 10.1097/YCT.0b013e3181f07948 [PubMed] [Cross Ref]
72. Esse Wilson J, Quinn DK, Wilson JK, et al. : Transcranial Direct Current Stimulation to the Right Temporoparietal Junction for Social Functioning in Autism Spectrum Disorder: A Case Report. J ECT. 2018;34(1):e10–e13. [PubMed] F1000 Recommendation
73. Park HR, Kim IH, Kang H, et al. : Nucleus accumbens deep brain stimulation for a patient with self-injurious behavior and autism spectrum disorder: functional and structural changes of the brain: report of a case and review of literature. Acta Neurochir (Wien). 2017;159(1):137–43. 10.1007/s00701-016-3002-2 [PubMed] [Cross Ref] F1000 Recommendation
74. Mahato RS, San Gabriel MC, Longshore CT, et al. : A Case of Treatment- resistant Depression and Body Dysmorphic Disorder: The Role of Electroconvulsive Therapy Revisited. Innov Clin Neurosci. 2016;13(7–8):37–40. [PMC free article] [PubMed] F1000 Recommendation
75. Kumar S, Singh S, Chadda RK, et al. : The Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation at Orbitofrontal Cortex in the Treatment of Patients With Medication-Refractory Obsessive-Compulsive Disorder: A Retrospective Open Study. J ECT. 2017. 10.1097/YCT.0000000000000462 [PubMed] [Cross Ref] F1000 Recommendation
76. Carmi L, Alyagon U, Barnea-Ygael N, et al. : Clinical and electrophysiological outcomes of deep TMS over the medial prefrontal and anterior cingulate cortices in OCD patients. Brain Stimul. 2018;11(1):158–65. 10.1016/j.brs.2017.09.004 [PubMed] [Cross Ref] F1000 Recommendation
77. Fettes P, Schulze L, Downar J: Cortico-Striatal-Thalamic Loop Circuits of the Orbitofrontal Cortex: Promising Therapeutic Targets in Psychiatric Illness. Front Syst Neurosci. 2017;11:25. 10.3389/fnsys.2017.00025 [PMC free article] [PubMed] [Cross Ref] F1000 Recommendation
閱讀更多 王翼心理 的文章
